Please login to the form below

Not currently logged in
Email:
Password:

OPKO appoints vice president of medical affairs

Dr Douglass Laidlaw brings experience from Relypsa and Sanofi

OPKO Health Dr Douglass LaidlawMiami-based OPKO Health has appointed Dr Douglass Laidlaw as vice president of medical affairs.

In his new role, Dr Laidlaw will be particularly responsible for overseeing the anticipated launch of the healthcare company's product Rayaldee.

Dr Laidlaw has over 15 years of experience in leading strategic planning, development and execution of medical education initiatives for numerous pharmaceutical companies, which include Genzyme, Keryx, Neurocine Biosciences and Serono.

He previously served as Relypsa's executive director, medical affairs and Sanofi's national director for medical science liasons, medical affairs.

Philip Frost, chairman and chief executive of OPKO, said: “Doug is a key addition to the management team in OPKO's renal division.

“A well-conceived and executed medical education strategy is critical to Rayaldee's acceptance by US healthcare professionals.”

6th June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics